29.4 C
New York
Thursday, June 11, 2026

Tag: guarantee

Let an AI Robot Take a Part-Time Job for You: CamdClaw Opens a New Way to Explore Automated Side Income

CamdClaw, an AI-assisted quantitative trading platform, is introducing a different idea: instead of spending more hours working yourself, users can explore market opportunities with the help of an automated AI trading assistant.
CamdClaw, an AI-assisted quantitative trading platform, is introducing a different idea: instead of spending more hours working yourself, users can explore market opportunities with the help of an automated AI trading assistant.

Wave Neuroscience Announces FDA Clearance of MeRT® for PTSD

FIRST-EVER FDA-CLEARED PERSONALIZED CLINICAL TREATMENT SYSTEM FOR POST-TRAUMATIC STRESS DISORDER (PTSD) ESTABLISHES A NEW CATEGORY IN PRECISION MENTAL HEALTHCARENEWPORT BEACH, Calif., June 11, 2026...

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Hope and inspiration: China-Greece cultural dialogue’s contemporary relevance

BEIJING, June 11, 2026 /PRNewswire/ -- A report from People's Daily: The second World Conference of Classics convened on June 9 and 10 in Athens,...

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the...

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026 in the securities class action first filed by the Firm.

Defiance ETFs to Launch SPCU, The 2X SpaceX ETF, as the SpaceX (SPCX) IPO Nears

Defiance ETFs to Launch SPCU, The 2X SpaceX ETF, as the SpaceX (SPCX) IPO Nears

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VERI

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Veritone, Inc. (NASDAQ: VERI) between October 14, 2025 and April 14, 2026, inclusive (the “Class Period”), of the important July 20, 2026 lead plaintiff deadline.

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Zillow Group, Inc. and Encourages Investors to Contact the...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zillow (Z) To Contact Him Directly To Discuss Their Options

Oh!mino Releases New Industry Report on Athletes Replacing Supplement Stacks with All-in-One EAA Formulas

Seal Beach, CA, June 10, 2026 (GLOBE NEWSWIRE) -- Oh!mino today released a new industry report examining the growing trend of athletes replacing supplement stacks with all-in-one essential amino acid (EAA) formulas. The report analyzes published research on muscle protein synthesis and recovery nutrition, highlighting increased interest in complete EAA formulations as athletes seek to simplify supplementation routines while supporting post-workout recovery and performance goals.

BABCOCK & WILCOX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Babcock & Wilcox Enterprises, Inc. Investors to Secure Counsel Before Important June 15 Deadline in...

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Babcock & Wilcox Enterprises, Inc. (“B&W”) (NYSE: BW) between November 5, 2025 and March 11, 2026, inclusive (the “Class Period”), of the important June 15, 2026 lead plaintiff deadline.

MoneySimpler Introduces AI Trading Automation Platform

Platform supports AI-assisted market monitoring, strategy workflow setup and account activity review
Platform supports AI-assisted market monitoring, strategy workflow setup and account activity review

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Lucid Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LCID

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Lucid Group, Inc. (NASDAQ: LCID) between February 25, 2026 and April 13, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 28, 2026.

Lear Investment Management’s Global Vigilance Moderate Risk SMA Earns 5-Star Morningstar Rating™

Recognition for 10-year performance underscores Lear's differentiated, research-driven approach to active managementDALLAS, June 10, 2026 /PRNewswire/ -- Lear Investment Management ("Lear"), a Dallas-based SEC-registered...

- A word from our sponsors -

spot_img
HomeTagsGuarantee